Literature DB >> 33567873

Aβ (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts.

A Kapasi1,2, S E Leurgans1,3, Z Arvanitakis1,3, L L Barnes1,3,4, D A Bennett1,3, J A Schneider1,2,3.   

Abstract

BACKGROUND AND
PURPOSE: There is increasing recognition of the importance of cortical microinfarcts to overall brain health, cognition, and Alzheimer dementia. Cerebral small vessel pathologies are associated with microinfarcts and frequently coexist with Alzheimer disease; however, the extent to which Aβ (amyloid beta) and tau pathology modulates microvascular pathogenesis is not fully understood. Study objective was to examine the relationship of small vessel pathologies, arteriolosclerosis, and cerebral amyloid angiopathy, with cortical microinfarcts in people with differing levels of Aβ or tau tangle burden.
METHODS: Participants were 1489 autopsied older people (mean age at death, 89 years; 67% women) from 1 of 3 ongoing clinical-pathological cohort studies of aging. Neuropathological evaluation identified cortical Aβ and tau tangle burden using immunohistochemistry in 8 brain regions, provided semiquantitative grading of cerebral vessel pathologies, and identified the presence of cortical microinfarcts. Logistic regression models adjusted for demographics and atherosclerosis and examined whether Aβ or tau tangle burden modified relations between small vessel pathologies and cortical microinfarcts.
RESULTS: Cortical microinfarcts were present in 17% of older people, moderate-to-severe cerebral amyloid angiopathy pathology in 36%, and arteriolosclerosis in 34%. In logistic regression models, we found interactions with Aβ and tau tangles, reflecting that the association between arteriolosclerosis and cortical microinfarcts was stronger in the context of greater Aβ (estimate, 0.15; SE=0.07; P=0.02) and tau tangle burden (estimate, 0.13; SE=0.06; P=0.02). Interactions also emerged for cerebral amyloid angiopathy, suggesting that the association between cerebral amyloid angiopathy and cortical microinfarcts is more robust in the presence of higher Aβ (estimate, 0.27; SE=0.07; P<0.001) and tangle burden (estimate, 0.16; SE=0.06; P=0.005).
CONCLUSIONS: These findings suggest that in the presence of elevated Aβ or tangle pathology, small vessel pathologies are associated with greater microvascular tissue injury, highlighting a potential link between neurodegenerative and vascular mechanisms.

Entities:  

Keywords:  Alzheimer disease; arteriolosclerosis; atherosclerosis; logistic models; longitudinal studies

Mesh:

Substances:

Year:  2021        PMID: 33567873      PMCID: PMC7902459          DOI: 10.1161/STROKEAHA.120.031073

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  38 in total

1.  Association of cortical microinfarcts and cerebral small vessel pathology in the ageing brain.

Authors:  E Kövari; F R Herrmann; G Gold; P R Hof; A Charidimou
Journal:  Neuropathol Appl Neurobiol       Date:  2017-03-07       Impact factor: 8.090

Review 2.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

3.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

4.  Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Authors:  Niklas Mattsson; Duygu Tosun; Philip S Insel; Alix Simonson; Clifford R Jack; Laurel A Beckett; Michael Donohue; William Jagust; Norbert Schuff; Michael W Weiner
Journal:  Brain       Date:  2014-03-12       Impact factor: 13.501

5.  The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts.

Authors:  Zoe Arvanitakis; Ana W Capuano; Sue E Leurgans; Aron S Buchman; David A Bennett; Julie A Schneider
Journal:  Brain Pathol       Date:  2016-04-14       Impact factor: 6.508

6.  Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts.

Authors:  Yoko Okamoto; Toru Yamamoto; Raj N Kalaria; Hideto Senzaki; Takakuni Maki; Yoshiki Hase; Akihiro Kitamura; Kazuo Washida; Mahito Yamada; Hidefumi Ito; Hidekazu Tomimoto; Ryosuke Takahashi; Masafumi Ihara
Journal:  Acta Neuropathol       Date:  2011-12-15       Impact factor: 17.088

7.  Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.

Authors:  Mario Merlini; Debora Wanner; Roger M Nitsch
Journal:  Acta Neuropathol       Date:  2016-03-17       Impact factor: 17.088

8.  Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.

Authors:  Rachel E Bennett; Ashley B Robbins; Miwei Hu; Xinrui Cao; Rebecca A Betensky; Tim Clark; Sudeshna Das; Bradley T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

9.  Functional deficits induced by cortical microinfarcts.

Authors:  Philipp M Summers; David A Hartmann; Edward S Hui; Xingju Nie; Rachael L Deardorff; Emilie T McKinnon; Joseph A Helpern; Jens H Jensen; Andy Y Shih
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-16       Impact factor: 6.200

10.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

View more
  9 in total

1.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 2.  Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease.

Authors:  Susanne J van Veluw; Konstantinos Arfanakis; Julie A Schneider
Journal:  Stroke       Date:  2022-01-10       Impact factor: 7.914

3.  Reducing Your Risk of Alzheimer's Dementia: Building a Better Brain as We Age.

Authors:  David A Bennett
Journal:  Arch Clin Neuropsychol       Date:  2021-10-13       Impact factor: 3.448

Review 4.  Effects of puerarin on chronic inflammation: Focus on the heart, brain, and arteries.

Authors:  Li Zhang; Lisheng Liu; Mingyi Wang
Journal:  Aging Med (Milton)       Date:  2021-12-15

5.  Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.

Authors:  Lei Yu; Zhiguang Huo; Jingyun Yang; Helena Palma-Gudiel; Patricia A Boyle; Julie A Schneider; David A Bennett; Jinying Zhao
Journal:  Front Aging Neurosci       Date:  2021-10-27       Impact factor: 5.750

Review 6.  Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions.

Authors:  Chen Ma; Fenfang Hong; Shulong Yang
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

7.  Systemic Inflammation Predicts Alzheimer Pathology in Community Samples without Dementia.

Authors:  Nicolas Cherbuin; Erin I Walsh; Liana Leach; Anne Brüstle; Richard Burns; Kaarin J Anstey; Perminder S Sachdev; Bernhard T Baune
Journal:  Biomedicines       Date:  2022-05-26

8.  Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?

Authors:  Geert Jan Biessels
Journal:  Brain       Date:  2022-08-27       Impact factor: 15.255

9.  Association of small vessel disease with tau pathology.

Authors:  Alifiya Kapasi; L Yu; V Petyuk; K Arfanakis; D A Bennett; J A Schneider
Journal:  Acta Neuropathol       Date:  2022-01-19       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.